Search

Your search keyword '"Bumma C"' showing total 116 results
Start Over Author "Bumma C"
116 results on '"Bumma C"'

104. High dose medroxyprogesterone acetate (MPA) treatment in metastatic carcinoma of the breast: a dose-response evaluation.

Author

Cuna GR, Calciati A, Strada MR, Bumma C, and Campio L

Subjects
Abscess chemically induced, Adult, Aged, Bone Neoplasms drug therapy, Clinical Trials as Topic, Dose-Response Relationship, Drug, Drug Evaluation, Female, Humans, Medroxyprogesterone toxicity, Middle Aged, Remission, Spontaneous, Time Factors, Breast Neoplasms drug therapy, Medroxyprogesterone administration & dosage, Neoplasm Metastasis drug therapy
Abstract

The results of controlled clinical trial that used high doses of medroxyprogesterone acetate (MPA) in the treatment of metastatic breast cancer are reported. Two treatment reigmens were used: regimen A, 500 mg daily with a total dose of 30 g; regimen B, 1,000 mg daily with a total dose of 60 g. The overall response rates were similar, with no statistically significant difference between the two treated groups. Regimen A (lower dosage group) reached a remission rate of 44%, whereas regimen B (higher dosage group) had a remission rate of 41%. The mean duration of response was 8 months with regimen A and 9 months with regimen B. The advantages of the lower dosage regimen as opposed to the higher dosage regimen of MPA in the treatment of advanced breast cancer are discussed.

Published
1978
Full Text
View/download PDF

105. [Neo-adjuvant chemotherapy].

Author

Bumma C, Perroni D, Grecchi GL, Lauria G, and Pautasso M

Subjects
Antineoplastic Combined Chemotherapy Protocols therapeutic use, Breast Neoplasms mortality, Carcinoma mortality, Female, Humans, Time Factors, Antineoplastic Agents therapeutic use, Breast Neoplasms drug therapy, Carcinoma drug therapy, Tamoxifen therapeutic use
Published
1988

106. [Description of a radiation-induced extraskeletal osteogenic sarcoma. Therapeutic implications].

Author

Marchetti G, Pelissero A, Russi E, Bumma C, Camuzzini G, Tortore P, and Comino A

Subjects
Breast Neoplasms radiotherapy, Carcinoma, Intraductal, Noninfiltrating radiotherapy, Female, Humans, Middle Aged, Neoplasms, Radiation-Induced pathology, Osteosarcoma diagnostic imaging, Osteosarcoma pathology, Radiography, Soft Tissue Neoplasms diagnostic imaging, Soft Tissue Neoplasms pathology, Time Factors, Neoplasms, Radiation-Induced etiology, Osteosarcoma etiology, Radiotherapy adverse effects, Soft Tissue Neoplasms etiology
Published
1989

108. [Diabetes, obesity and adenocarcinoma of corpus uteri].

Author

Bumma C, Calciati A, Cacciari P, La Grotta G, and Falda M

Subjects
Adenocarcinoma therapy, Adult, Aged, Female, Humans, Middle Aged, Uterine Neoplasms therapy, Adenocarcinoma complications, Diabetes Complications, Obesity complications, Uterine Neoplasms complications
Abstract

Diabetes and obesity were noted in 21.3% and 42.3% respectively of 94 patients with adenocarcinoma corporis uteri. Hypertension and ovarian or mammary neoplasia were also common. Obese and diabetic subjects proved more sensitive to treatment with high doses of medroxyprogesterone acetate. Screening for precancerous states or carcinoma of the endometrium in obese and diabetic women is suggested.

Published
1976

110. [Immunologic problems of diabetes mellitus].

Author

Carta Q, Bumma C, and Lanfranco G

Subjects
Adult, Aged, Amino Acids immunology, Antibody Formation, Antigen-Antibody Reactions, Child, Child, Preschool, Diabetes Mellitus drug therapy, Diabetes Mellitus, Type 1 drug therapy, Female, Histocompatibility Antigens, Humans, Immunity, Cellular, Immunoglobulins, Immunologic Memory, Insulin therapeutic use, Insulin Antibodies, Male, Middle Aged, Diabetes Mellitus immunology
Published
1974

113. [Evaluation of rosette E forming lymphocytes during therapy with Peptichemio].

Author

Bumma C, Calciati A, Falda M, La Grotta G, and Gino GC

Subjects
Aged, Antibody Formation drug effects, Humans, Middle Aged, Neoplasms immunology, Immune Adherence Reaction, Lymphocytes drug effects, Neoplasms drug therapy, Nitrogen Mustard Compounds therapeutic use, Peptichemio therapeutic use
Published
1974

114. [Results in 67 patients with malignant tumors treated by Peptichemio].

Author

Calderini P, Calciati A, Bumma C, Santoro L, and Valli M

Subjects
Clinical Trials as Topic, Drug Evaluation, Female, Humans, Male, Peptichemio adverse effects, Neoplasms drug therapy, Nitrogen Mustard Compounds therapeutic use, Peptichemio therapeutic use
Published
1974

115. [Gamma GT in the diagnosis of primary and secondary hepatic neoplasms].

Author

Lanfranco G, Gino GC, Bumma C, de Fillippi PG, Calciati A, Scuro S, La Grotta G, and Bossi E

Subjects
Acyltransferases blood, Adenocarcinoma enzymology, Adolescent, Adult, Aged, Bile Duct Neoplasms enzymology, Bone Neoplasms enzymology, Breast Neoplasms enzymology, Carcinoma enzymology, Carcinoma, Hepatocellular enzymology, Female, Gastrointestinal Neoplasms enzymology, Genital Neoplasms, Female enzymology, Hodgkin Disease enzymology, Humans, L-Lactate Dehydrogenase blood, Liver Neoplasms enzymology, Lung Neoplasms enzymology, Male, Melanoma enzymology, Middle Aged, Neoplasm Metastasis diagnosis, Neoplasm Metastasis enzymology, Osteosarcoma enzymology, Phosphoric Monoester Hydrolases blood, Transaminases blood, Liver Neoplasms diagnosis, gamma-Glutamyltransferase blood
Published
1974

116. [Hypoglycemia in extra-pancreatic tumors].

Author

Bumma C, Calciati A, Gino GC, La Grotta G, and Sala A

Subjects
Adult, Aged, Blood Glucose analysis, Female, Glucose Tolerance Test, Humans, Insulin blood, Male, Middle Aged, Pancreas physiopathology, Radioimmunoassay, Hypoglycemia etiology, Neoplasms complications
Published
1971

Catalog

Books, media, physical & digital resources
See catalog results